Approval · Notice of Compliance 1681 · 2001
PENTASA: Notice of Compliance 1681
Issued April 30, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1681
- Date
- April 30, 2001
- Company
- Ferring Inc.North York, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to product monograph
- Therapeutic class
- Gastrointestinal anti-inflammatory
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PENTASA | Not yet assigned | — |
Medicinal ingredients
- MESALAZINE 250 MG per TAB
- MESALAZINE 500 MG per TAB
- MESALAZINE 1 G per 100ML
- MESALAZINE 2 G per 100ML
- MESALAZINE 4 G per 100ML
- MESALAZINE 1 G per SUP